SE8306661L - Forfarande och test-sats for diagnostisering av cancer pa menniskor - Google Patents

Forfarande och test-sats for diagnostisering av cancer pa menniskor

Info

Publication number
SE8306661L
SE8306661L SE8306661A SE8306661A SE8306661L SE 8306661 L SE8306661 L SE 8306661L SE 8306661 A SE8306661 A SE 8306661A SE 8306661 A SE8306661 A SE 8306661A SE 8306661 L SE8306661 L SE 8306661L
Authority
SE
Sweden
Prior art keywords
human cancer
diagnosis
procedure
test rate
urine
Prior art date
Application number
SE8306661A
Other languages
Unknown language ( )
English (en)
Other versions
SE455824B (sv
SE8306661D0 (sv
Inventor
B S Vold
Original Assignee
Stanford Res Inst Int
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Stanford Res Inst Int filed Critical Stanford Res Inst Int
Publication of SE8306661L publication Critical patent/SE8306661L/sv
Publication of SE8306661D0 publication Critical patent/SE8306661D0/sv
Publication of SE455824B publication Critical patent/SE455824B/sv

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/5308—Immunoassay; Biospecific binding assay; Materials therefor for analytes not provided for elsewhere, e.g. nucleic acids, uric acid, worms, mites
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57484—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites
    • G01N33/57488—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites involving compounds identifable in body fluids

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Pathology (AREA)
  • Biotechnology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Microbiology (AREA)
  • General Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Hospice & Palliative Care (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Oncology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
SE8306661A 1982-04-23 1983-12-02 Forfarande, testsats och monoklonal antikropp for bestemning av cancerassocierad nukleosid SE455824B (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US37128782A 1982-04-23 1982-04-23

Publications (3)

Publication Number Publication Date
SE8306661L true SE8306661L (sv) 1983-12-02
SE8306661D0 SE8306661D0 (sv) 1983-12-02
SE455824B SE455824B (sv) 1988-08-08

Family

ID=23463339

Family Applications (1)

Application Number Title Priority Date Filing Date
SE8306661A SE455824B (sv) 1982-04-23 1983-12-02 Forfarande, testsats och monoklonal antikropp for bestemning av cancerassocierad nukleosid

Country Status (5)

Country Link
EP (1) EP0106894B1 (sv)
DE (1) DE3342807C2 (sv)
GB (1) GB2129934B (sv)
SE (1) SE455824B (sv)
WO (1) WO1983003903A1 (sv)

Also Published As

Publication number Publication date
DE3342807C2 (de) 1994-06-23
EP0106894A4 (en) 1984-09-06
SE455824B (sv) 1988-08-08
DE3342807T1 (de) 1984-05-03
WO1983003903A1 (en) 1983-11-10
EP0106894B1 (en) 1986-10-15
GB2129934B (en) 1985-06-05
EP0106894A1 (en) 1984-05-02
SE8306661D0 (sv) 1983-12-02
GB2129934A (en) 1984-05-23
GB8334051D0 (en) 1984-02-01

Similar Documents

Publication Publication Date Title
Taylor et al. Autoimmune phenomena in pernicious anaemia: gastric antibodies
Tolo et al. Serum antibodies and loss of periodontal bone in patients with rheumatoid arthritis
Arbesman et al. IgE levels in sera of patients with pemphigus or bullous pemphigoid
Purves et al. Serum alpha‐feto‐protein and primary cancer of the liver in man
Jordan et al. Direct immunofluorescent studies of pemphigus and bullous pemphigoid
FI821822A (fi) Paovisningsfoerfarande
SE7906148L (sv) Forfarande for framstellning av en biologisk komposition for anvendning sasom referenskontroll vid diagnostiska tester
Elhilali et al. Critical evaluation of lymphocyte functions in urological cancer patients
Kaufmann et al. Immunomorphological lymph node changes in patients with operable bronchogenic squamous cell carcinoma
DK509686D0 (da) Fremgangsmaade og apparat til bestemmelse af antistofindholdet i blod
ES2033823T3 (es) Ensayo en cuanto a cancer de mama humano.
Rothenbacher et al. Active infection with Helicobacter pylori in an asymptomatic population of middle aged to elderly people
Shillitoe et al. Five‐year survival of patients with oral cancer and its association with antibody to herpes simplex virus
Fireman et al. Reproducibility studies and effects of bowel preparations on measurements of rectal epithelial proliferation
Kalwinsky et al. Clinical utility of initial terminal deoxynucleotidyl transferase determinations in childhood acute leukemias
Gholami et al. Parental risk factors of childhood acute leukemia: a case-control study
Vinzenz et al. Serum immunoglobulin levels in patients with head and neck cancer (IgE, IgA, IgM, IgG)
SE8306661L (sv) Forfarande och test-sats for diagnostisering av cancer pa menniskor
Medara et al. Peripheral memory T‐cell profile is modified in patients undergoing periodontal management
Ben-Aryeh et al. Sialochemistry of patients with rheumatoid arthritis: Electrolytes, protein, and salivary IgA
OA08331A (fr) Anticorps monoclonaux, lignées de cellules et trousses les contenant pour diagnostiquer les épithéliomas de poumons humains ne comportant pas de petites cellules;
SE8406416L (sv) Forfarande och test-sats for diagnostisering av cancer pa menniskor
Adler-Storthz et al. A prospective study of herpes simplex virus infection in a defined population in Houston, Texas
Monroe Vitiligo associated with regional enteritis
Itahashi et al. Immunoradiometrical measurement of tissue polypeptide antigen (TPA) and cancer antigen 125 (CA125) in pregnancy and at delivery

Legal Events

Date Code Title Description
NUG Patent has lapsed

Ref document number: 8306661-3

Effective date: 19941110

Format of ref document f/p: F